Primary therapy with single agent bortezomib as induction, maintenance, and re-Induction in patients with high risk myeloma: results of the ECOG E2A02 trial

por Dispenzieri, Angela, Jacobus, Susanna, Vesole, David H., Callandar, Natalie, Fonseca, Rafael, Greipp, Philip R.
Publicado 2010

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

por Van Ness, Brian, Ramos, Christine, Haznadar, Majda, Hoering, Antje, Haessler, Jeff, Crowley, John, Jacobus, Susanna, Oken, Martin, Rajkumar, Vincent, Greipp, Philip, Barlogie, Bart, Durie, Brian, Katz, Michael, Atluri, Gowtham, Fang, Gang, Gupta, Rohit, Steinbach, Michael, Kumar, Vipin, Mushlin, Richard, Johnson, David, Morgan, Gareth
Publicado 2008